Search results
Found 7347 matches for
Our partners AstraZeneca have today announced the high-level results from the primary analysis of their Phase III trial of the ChAdOx1 nCoV-19 coronavirus vaccine in the US. They confirm that the vaccine efficacy is consistent with the interim analysis results announced on Monday 22 March 2021.
©
John Cairns
MLSTF Summer 2024 - Minutes
Minutes from MLSTF 2024 Panel meeting
Guidance For Applicants FA Alliance Catalyst
Guidance For Applicants